Advances in Systemic Treatment of Bladder Cancer
Advances in Systemic Treatment of Bladder Cancer
Dr. Michael Ong, MD FRCPC
Medical Oncologist | The Ottawa Hospital
The Ottawa Hospital Cancer Centre
Cancer Treatment Across Eastern Ontario
PEMBROKE
RENFREW
OTTAWA
(QUEENSWAY)
OTTAWA
(TOHCC)
HAWKESBURY
WINCHESTER
CORNWALL
TOHCC Research Network
Clinical Trials Program
New Drug (IND)
Program
Site Chair 7 Investigators 2 Start Up Specialists 3 Study Coordinators 2 Data Managers
65 Oncologists
(23 Med, 20 Rad, 17 Surg, 5 Gyne) 1 Medical Director Clinical Research 1 Clinical Research Program Manager 1 Quality Supervisor 20 Study Coordinators 5 Start Up Specialists 6 Data Managers 1 Research Pharmacist 4 Pharmacy Research Technicians 1 Pharmacology Supervisor 3.5 Pharmacology Nurses 2 Laboratory Technicians
"Conventional" Cancer Treatments
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- review clinical trial outcomes
- a pan european comparison regarding patient access to
- advances in lung cancer treatment lsu health new orleans
- advances in systemic treatment of bladder cancer
- advances in the treatment of colorectal cancer
- advances in cancer treatment
- impact of new personalised cancer treatments draft do not
Related searches
- advances in cancer therapy
- advances in cancer treatment
- technology advances in cancer treatment
- advances in cancer treatment 2018
- bladder cancer treatment side effects
- bladder cancer treatment drugs
- signs of bladder cancer men
- symptoms of bladder cancer men
- bladder cancer treatment options
- symptoms of bladder cancer in women
- signs of bladder cancer in women
- causes of bladder cancer in women